{"id":"NCT02709655","sponsor":"H. Lundbeck A/S","briefTitle":"Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)","officialTitle":"Interventional, Randomized, Double-blind, Placebo-controlled, Active-reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years, With Major Depressive Disorder (MDD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-05-18","primaryCompletion":"2022-01-21","completion":"2022-01-21","firstPosted":"2016-03-16","resultsPosted":"2022-09-22","lastUpdate":"2022-09-22"},"enrollment":683,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Depressive Disorder, Major"],"interventions":[{"type":"DRUG","name":"Vortioxetine 10 mg/day","otherNames":["Brintellix ®","Lu AA21004"]},{"type":"DRUG","name":"Vortioxetine 20 mg/day","otherNames":["Brintellix ®","Lu AA21004"]},{"type":"DRUG","name":"Fluoxetine 20mg/day","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Vortioxetine 10 mg/day","type":"EXPERIMENTAL"},{"label":"Vortioxetine 20 mg/day","type":"EXPERIMENTAL"},{"label":"Fluoxetine 20 mg/day,","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Investigation of the efficacy and safety of a new potential treatment of Major depressive disorder (MDD) in paediatric participants (age 7 to 11 years).","primaryOutcome":{"measure":"Change From Baseline in Children Depression Rating Scale - Revised (CDRS-R) Total Score at Week 8 of Phase B","timeFrame":"Baseline (Week 4 of Phase A), Week 8 of Phase B","effectByArm":[{"arm":"Double-Blind: Placebo","deltaMin":-17.48,"sd":1.35},{"arm":"Double-Blind: Vortioxetine 10 mg","deltaMin":-19.2,"sd":1.37},{"arm":"Double-Blind: Vortioxetine 20 mg","deltaMin":-19.94,"sd":1.37},{"arm":"Double-Blind: Fluoxetine 20 mg","deltaMin":-20.78,"sd":1.6},{"arm":"Vortioxetine Average (Avg. VOR)","deltaMin":-19.57,"sd":1.16}],"pValues":[{"comp":"OG000 vs OG004","p":"0.0937"},{"comp":"OG000 vs OG001","p":"0.2336"},{"comp":"OG000 vs OG002","p":"0.0879"},{"comp":"OG000 vs OG003","p":"0.0531"}]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":98,"countries":["United States","Bulgaria","Canada","Colombia","Estonia","France","Germany","Hungary","Israel","Italy","Latvia","Mexico","Poland","Russia","Serbia","South Africa","South Korea","Spain","Ukraine"]},"refs":{"pmids":["40922774"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":677},"commonTop":["Headache","Nausea","Vomiting","Nasopharyngitis","Abdominal pain upper"]}}